decisionhealth Newsletters, Coder Pink Sheets - 2007 Issue 6 (June)
Zostavax vaccine clarification
Subscribe or sign in to view the full article.
Article Overview
This short article addresses a Medicare billing clarification for the shingles vaccine Zostavax. It is relevant to primary care practices, billing staff, and coders who handle vaccine claims and need to understand the coverage distinction between Medicare Part D and Part B as discussed in a CMS Open Door Forum context.
Why This Topic Matters
The article helps readers identify when vaccine-related billing can be considered under Medicare coverage pathways and highlights that the guidance applies only for a specific year. It is useful for practices trying to avoid claim submission errors for vaccine administration.
What You Will Learn
- How the article frames Medicare coverage for a shingles vaccine billing question.
- What general billing topic was clarified in response to a CMS Open Door Forum question.
- Which type of practice and billing scenario the clarification applies to.
- How the article distinguishes vaccine coverage considerations by Medicare plan participation.
Who Should Read This
- Primary care physicians
- Medical coders
- Billing staff
- Practice managers
- Revenue cycle staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com